Central New York Cardiology
Utica, New York, United States
Cardiologist in Utica, New York
5988, 2211 Genesee St, Utica, NY 13501
About Central New York Cardiology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Medtronic
2
Pfizer
2
Gilead Sciences
1
Medtronic Cardiac Rhythm and Heart Failure
1
Clinical Trials at Central New York Cardiology
During the past decade, Central New York Cardiology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Model 4396 Left Ventricular (LV) Lead Chronic Performance Study
2011-05-01
2021-02-04
Completed
366
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
2011-10-01
2015-02-01
Completed
2,651
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Central New York Cardiology
According to Clinical.Site data, the most researched conditions in "Central New York Cardiology" are
"Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Angina Pectoris" (1 trials), "Coronary Artery Disease" (1 trials) and "Heart Failure With Left Bundle Branch Block" (1 trials). Many other conditions were trialed in "Central New York Cardiology" in a lesser frequency.
Clinical Trials Intervention Types at Central New York Cardiology
Most popular intervention types in "Central New York Cardiology" are "Drug" (3 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Cardiac Resynchronization Therapy - MPP" (1 trials), "Ranolazine" (1 trials) and "aCRT OFF" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Central New York Cardiology
The vast majority of trials in "Central New York Cardiology" are
6 trials for "All" genders.
Clinical Trials Status at Central New York Cardiology
Currently, there are NaN active trials in "Central New York Cardiology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Central New York Cardiology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Central New York Cardiology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".